Individual results may vary, and the compound may not be suitable for all individuals
Inhibition of NNMT by 5-Amino-1MQ and Its Effects on Fat Metabolism. Cellular Metabolism , 33(7), 1345-1358
While its safety profile was consistently favorable, the largest Phase IIb trial failed to show statistical significance for weight loss, and commercial development was halted in 2007.[2] Despite this, interest in AOD-9604 has continued in the compounding pharmacy and integrative medicine space, particularly given its safety data, its lack of IGF-1 stimulation, and emerging research around joint health
$30.00Purchase & earn 30 points
It increases growth hormone receptor expression in tendon fibroblasts at both mRNA and protein levels, with effects lasting at least three days